Pipeline
We are advancing three clinic-ready compounds to be tested exclusively in pediatric cancers. Our focus is simple and unwavering: accelerate the development of new therapies for children who have been left behind by traditional drug models.
Volasertib
-
Description text goes here
-
Description text goes here
-
Description text goes here
Dovitinib
-
Description text goes here
-
Description text goes here
-
Description text goes here
Stenoparib
-
Description text goes here
-
Description text goes here
-
Description text goes here